• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基酸作为低水溶解性药物的共无定形稳定剂-第 2 部分:分子相互作用。

Amino acids as co-amorphous stabilizers for poorly water-soluble drugs--Part 2: molecular interactions.

机构信息

School of Pharmacy, University of Otago, Dunedin, New Zealand; Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.

出版信息

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):882-8. doi: 10.1016/j.ejpb.2013.03.026. Epub 2013 Apr 6.

DOI:10.1016/j.ejpb.2013.03.026
PMID:23567485
Abstract

The formation of co-amorphous drug-drug mixtures has proved to be a powerful approach to stabilize the amorphous form and at the same time increase the dissolution of poorly water-soluble drugs. Molecular interactions in these co-amorphous formulations can play a crucial role in stabilization and dissolution enhancement. In this regard, Fourier-transform infrared spectroscopy (FTIR) is a valuable tool to analyze the molecular near range order of the compounds in the co-amorphous mixtures. In this study, several co-amorphous drugs--low molecular weight excipient blends--have been analyzed with FTIR spectroscopy. Molecular interactions of the drugs carbamazepine and indomethacin with the amino acids arginine, phenylalanine, and tryptophan were investigated. The amino acids were chosen from the biological target site of both drugs and prepared as co-amorphous formulations together with the drugs by vibrational ball milling. A detailed analysis of the FTIR spectra of these formulations revealed specific peak shifts in the vibrational modes of functional groups of drug and amino acid, as long as one amino acid from the biological target site was present in the blends. These peak shifts indicate that the drugs formed specific molecular interactions (hydrogen bonding and π-π interactions) with the amino acids. In the drug-amino acid mixtures that contained amino acids which were not present at the biological target site, no such interactions were identified. This study shows the potential of amino acids as small molecular weight excipients in co-amorphous formulations to stabilize the amorphous form of a poorly water-soluble drug through strong and specific molecular interactions with the drug.

摘要

共无定形药物混合物的形成已被证明是一种稳定无定形形式并同时提高难溶性药物溶解度的有力方法。这些共无定形制剂中的分子相互作用在稳定和溶解增强方面可以发挥关键作用。在这方面,傅里叶变换红外光谱(FTIR)是分析共无定形混合物中化合物分子近程有序的有价值的工具。在这项研究中,使用 FTIR 光谱分析了几种共无定形药物 - 低分子量赋形剂混合物。研究了药物卡马西平和吲哚美辛与氨基酸精氨酸、苯丙氨酸和色氨酸的分子相互作用。选择了这两种药物的生物靶位的氨基酸,并通过振动球磨与药物一起制备成共无定形制剂。对这些制剂的 FTIR 光谱的详细分析表明,只要混合物中存在生物靶位的一种氨基酸,药物和氨基酸的官能团振动模式就会出现特定的峰位移。这些峰位移表明药物与氨基酸形成了特定的分子相互作用(氢键和π-π相互作用)。在含有生物靶位不存在的氨基酸的药物-氨基酸混合物中,没有鉴定出这种相互作用。这项研究表明,氨基酸作为共无定形制剂中的小分子赋形剂具有潜力,通过与药物的强特异性分子相互作用稳定难溶性药物的无定形形式。

相似文献

1
Amino acids as co-amorphous stabilizers for poorly water-soluble drugs--Part 2: molecular interactions.氨基酸作为低水溶解性药物的共无定形稳定剂-第 2 部分:分子相互作用。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):882-8. doi: 10.1016/j.ejpb.2013.03.026. Epub 2013 Apr 6.
2
Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.氨基酸作为低水溶解性药物的共无定形稳定剂——第 1 部分:制备、稳定性和溶出度的提高。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):873-81. doi: 10.1016/j.ejpb.2013.03.014. Epub 2013 Mar 26.
3
Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.氨基酸作为辛伐他汀和格列本脲的共无定形辅料:物理性质与稳定性
Mol Pharm. 2014 Jul 7;11(7):2381-9. doi: 10.1021/mp500107s. Epub 2014 Jun 4.
4
Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.氨基酸作为共无定形辅料用于解决缬沙坦水溶性差的问题。
Pharm Dev Technol. 2017 Feb;22(1):69-76. doi: 10.3109/10837450.2016.1163390. Epub 2016 Apr 6.
5
Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.喷雾干燥共无定形药物 - 氨基酸盐的制备与表征
J Pharm Pharmacol. 2016 May;68(5):615-24. doi: 10.1111/jphp.12458. Epub 2015 Aug 5.
6
Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.多组份共无定形盐片的制备与特性研究:将多模态非线性光学成像与成熟的分析方法相结合。
Eur J Pharm Biopharm. 2018 Nov;132:112-126. doi: 10.1016/j.ejpb.2018.09.013. Epub 2018 Sep 22.
7
Application of a Salt Coformer in a Co-Amorphous Drug System Dramatically Enhances the Glass Transition Temperature: A Case Study of the Ternary System Carbamazepine, Citric Acid, and l-Arginine.盐共晶剂在共无定形药物系统中的应用显著提高玻璃化转变温度:以卡马西平、柠檬酸和 l-精氨酸的三元体系为例。
Mol Pharm. 2018 May 7;15(5):2036-2044. doi: 10.1021/acs.molpharmaceut.8b00174. Epub 2018 Apr 13.
8
A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.喷雾干燥和粉碎在磺胺噻唑/聚乙烯吡咯烷酮和磺胺嘧啶/聚乙烯吡咯烷酮无定形分散体制备中的比较。
Mol Pharm. 2011 Apr 4;8(2):532-42. doi: 10.1021/mp1003674. Epub 2011 Mar 3.
9
Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.通过机械活化制备的无定形吲哚美辛和盐酸雷尼替丁二元体系的物理表征及稳定性
Eur J Pharm Biopharm. 2009 Jan;71(1):47-54. doi: 10.1016/j.ejpb.2008.06.022. Epub 2008 Jul 3.
10
Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethacin.共无定形氨基酸-吲哚美辛混合物的溶出行为:氨基酸稳定吲哚美辛过饱和状态的能力。
Eur J Pharm Biopharm. 2017 Mar;112:85-95. doi: 10.1016/j.ejpb.2016.11.023. Epub 2016 Nov 22.

引用本文的文献

1
Biofunctional Excipients: Their Emerging Role in Overcoming the Inherent Poor Biopharmaceutical Characteristics of Drugs.生物功能性辅料:它们在克服药物固有的不良生物药剂学特性方面的新兴作用。
Pharmaceutics. 2025 May 1;17(5):598. doi: 10.3390/pharmaceutics17050598.
2
Co-Amorphization of Acemetacin with Basic Amino Acids as Co-Formers for Solubility Improvement and Gastric Ulcer Mitigation.以碱性氨基酸为共形成物对阿西美辛进行共无定形化以改善溶解度和减轻胃溃疡
Pharmaceutics. 2024 May 31;16(6):745. doi: 10.3390/pharmaceutics16060745.
3
Amorphization of Low Soluble Drug with Amino Acids to Improve Its Therapeutic Efficacy: a State-of-Art-Review.
氨基酸对低溶性药物进行非晶化以提高其治疗效果:综述。
AAPS PharmSciTech. 2023 Dec 7;24(8):253. doi: 10.1208/s12249-023-02709-2.
4
Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone.通过与氯苯那敏和聚乙烯吡咯烷酮制备共无定形固体分散体提高氯雷他定的溶解度和物理稳定性
Pharmaceutics. 2023 Oct 31;15(11):2558. doi: 10.3390/pharmaceutics15112558.
5
Sugars and Polyols of Natural Origin as Carriers for Solubility and Dissolution Enhancement.天然来源的糖类和多元醇作为提高溶解度和溶出度的载体
Pharmaceutics. 2023 Oct 30;15(11):2557. doi: 10.3390/pharmaceutics15112557.
6
Coamorphous Systems of Valsartan: Thermal Analysis Contribution to Evaluate Intermolecular Interactions Effects on the Structural Relaxation.缬沙坦的共无定形系统:热分析对评估分子间相互作用对结构弛豫影响的贡献。
Molecules. 2023 Aug 25;28(17):6240. doi: 10.3390/molecules28176240.
7
Sinapic Acid Co-Amorphous Systems with Amino Acids for Improved Solubility and Antioxidant Activity.与氨基酸形成的咖啡酸共无定形系统,提高了溶解度和抗氧化活性。
Int J Mol Sci. 2023 Mar 14;24(6):5533. doi: 10.3390/ijms24065533.
8
Considerations on the Kinetic Processes in the Preparation of Ternary Co-Amorphous Systems by Milling.关于通过研磨制备三元共非晶体系中动力学过程的思考。
Pharmaceutics. 2023 Jan 3;15(1):172. doi: 10.3390/pharmaceutics15010172.
9
Mechanical Activation by Ball Milling as a Strategy to Prepare Highly Soluble Pharmaceutical Formulations in the Form of Co-Amorphous, Co-Crystals, or Polymorphs.通过球磨进行机械活化作为制备共无定形、共晶体或多晶型物形式的高溶解性药物制剂的策略。
Pharmaceutics. 2022 Sep 21;14(10):2003. doi: 10.3390/pharmaceutics14102003.
10
Enhancement of the Bioavailability and Anti-Inflammatory Activity of Glycyrrhetinic Acid via Novel Soluplus-A Glycyrrhetinic Acid Solid Dispersion.通过新型Soluplus-甘草次酸固体分散体提高甘草次酸的生物利用度和抗炎活性
Pharmaceutics. 2022 Aug 26;14(9):1797. doi: 10.3390/pharmaceutics14091797.